Deutsche Bank lowered the firm’s price target on Roche (RHHBY) to CHF 250 from CHF 265 and keeps a Sell rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RHHBY:
- Roche downgraded to Hold from Buy at HSBC
- Roche price target lowered to CHF 286 from CHF 312 at Morgan Stanley
- Genentech announces CENTERSTONE trial data published in NEJM
- Trump Trade: Auto makers exempt from some U.S. tariffs
- Roche seeking U.S. tariff relief in direct talks with White House, Reuters says